Skip to main content
TipRanks
Go Ultimate75% OFF

Robert Bindert Huizinga Insider Profile

4 Followers

Robert Bindert Huizinga, EVP of Research at Aurinia Pharmaceuticals, holds 69.38K shares in Aurinia Pharmaceuticals (Ticker: AUPH).

Robert Bindert Huizinga's Trading History

AUPH
Aurinia Pharmaceuticals
Mar 04, 2022EVP of ResearchUninformative Buy―$1.09M
AUPH
Insider Shares: 69.38K (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 04, 2022Informative Sell$58.24K4,849$12.01―
Mar 04, 2022Uninformative Buy$0.008,500$0.00―
Oct 26, 2021Uninformative Sell$3.87M130,000$29.75―
Oct 26, 2021Uninformative Buy$304.00K95,000$3.20―
Sep 22, 2021Uninformative Sell$779.53K32,500$23.98―

You May Also Like

Robert Bindert Huizinga insider profile FAQ

What stocks does Robert Bindert Huizinga hold?
Robert Bindert Huizinga holds: AUPH stocks.
What is Robert Bindert Huizinga's role in Aurinia Pharmaceuticals?
Robert Bindert Huizinga's role in Aurinia Pharmaceuticals is EVP of Research.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.